PNC FINANCIAL SERVICES GROUP, INC.

Position in OCUL — Ocular Therapeutix, Inc

CIK 713676 Pittsburgh, PA

Position in OCUL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$9,397

+$4,239 QoQ

Shares Held

957

+57.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#231

of 257 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. OCUL ranks #141 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	69,358	$34,452,195
2	REGN	Regeneron Pharmaceuticals, Inc.	16,662	$10,389,420
3	TECH	BIO-TECHNE Corp	77,074	$5,445,277
4	MRNA	Moderna, Inc.	70,829	$4,960,151
5	TGTX	Tg Therapeutics, Inc.	89,646	$4,925,149
6	DNTH	Dianthus Therapeutics, Inc. /DE/	39,473	$3,847,827
7	INCY	Incyte Corp	32,777	$3,715,597
8	ARGX	Argenx SE	3,967	$3,680,460

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,397	957	+57.1%	Shares	Defined	2026-08-07
2026-03-31	$5,158	609	-10.7%	Shares	Defined	2026-05-08
2025-12-31	$8,279	682	-6.1%	Shares	Defined	2026-02-06
2025-09-30	$8,485	726	+42.1%	Shares	Defined	2025-11-07
2025-06-30	$4,742	511	+80.6%	Shares	Defined	2025-08-08
2025-03-31	$2,074	283	+167.0%	Shares	Defined	2025-05-09
2024-06-30	$725	106	-13.1%	Shares	Defined	2024-08-09
2024-03-31	$1,110	122	+1009.1%	Shares	Defined	2024-05-10
2023-12-31	$49	11	-98.9%	Shares	Defined	2024-03-22
2021-12-31	$6,970	1,000	—	Shares	Defined	2022-02-11
No filing history on record for this holder in this stock.